Frailty and multi-morbidities should not govern oral anticoagulation therapy prescribing for patients with atrial fibrillation

Am Heart J. 2019 Feb:208:120-122. doi: 10.1016/j.ahj.2018.10.003. Epub 2018 Oct 31.

Authors

Ameenathul M Fawzy¹, Brian Olshansky², Gregory Y H Lip³

Affiliations

¹ Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.
² University of Iowa Hospitals, Iowa City, Iowa.
³ Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom. Electronic address: gregory.lip@liverpool.ac.uk.

PMID: 30487073
DOI: 10.1016/j.ahj.2018.10.003

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anticoagulants
Atrial Fibrillation*
Frailty*
Humans
Pyrazoles
Pyridones
Warfarin

Substances

Anticoagulants
Pyrazoles
Pyridones
apixaban
Warfarin